Tag: Covid-19
-
Point-of-Care Covid-19 Diagnostic Shows High Accuracy
A test for SARS-CoV-2 viruses in humans is shown in field tests to return diagnostic results in 90 minutes with accuracy comparable to the gold-standard RT-PCR test.
-
Early Trial Results Show Antibody Treating Covid-19
First results from a clinical trial testing an experimental synthetic antibody, show patients receiving the therapy at a specific dosage, cleared their SARS-CoV-2 viruses within 11 days.
-
NIH Trials Testing Covid-19 Blood Clot Therapies
National Institutes of Health is starting two clinical trials testing a number of blood thinning treatments for people with blood clots from Covid-19 infections.
-
Antibody Discovery Company Forms, Partners on Covid-19
A new enterprise formed to discover human therapeutic antibodies is partnering with a synthetic biology company to discover Covid-19 antibody treatments.
-
Small Biz Grant Funds Covid-19 Disinfectant Spray
A Florida start-up company is developing a fast-acting disinfectant spray that dries on contact, yet still kills Covid-19 viruses on surfaces.
-
Phone Data Show Stay-Home, Distancing Order Effects
Anonymous data collected from millions of mobile phones last spring show stay-at-home and social distancing orders helped slow the spread of Covid-19 in the U.S.
-
Biotechs, Pharmas Vow Not to Rush Covid-19 Vaccines
In a joint statement today, CEOs of nine companies promised to follow the highest ethical and scientific standards in development and testing of their Covid-19 vaccines.
-
Small Antibody Shown to Block Covid-19 Infection
Researchers in Sweden found a small-scale antibody grown in an alpaca that in lab tests blocks the SARS-CoV-2 infection mechanism.
-
Infographic – Willingness to Take Covid-19 Vaccine
The chart shows data from surveys by polling company Ipsos MORI in 27 countries at the end of July and beginning of August, for the World Economic Forum.
-
Sanofi, GSK Begin U.S. Covid-19 Vaccine Trial
Global drug makers Sanofi and GlaxoSmithKline are starting a clinical trial testing a vaccine to prevent Covid-19 infections among healthy adults in the U.S.